Keywords: Grifols, Araclon Biotech, Alzheimer's disease, Vaccines, Diagnostics, M&A

Grifols acquires 51% stake in Araclon Biotech

Article | 19 March 2012

Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based company Araclon Biotech, ensuring the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Grifols

Araclon Biotech

Go to company listing